These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4395162)

  • 1. Treatment and pretreatment of graft-versus-host reaction by antilymphocyte serum.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):397-406. PubMed ID: 4395162
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of antilymphocyte serum on graft-versus-host reactivity.
    Haskovcová H; Nouza K
    Folia Biol (Praha); 1970; 16(6):391-6. PubMed ID: 4394680
    [No Abstract]   [Full Text] [Related]  

  • 3. [Graft-versus-host reactions: models, susceptibility to control, and clinical analogies].
    Brune K
    Schweiz Med Wochenschr; 1970 Jan; 100(2):49-58. PubMed ID: 4400853
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclophosphamide-induced graft-versus-host immunotolerance.
    Van Winkle MG
    J Reticuloendothel Soc; 1971 Nov; 10(5):403-17. PubMed ID: 4399566
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the host.
    Boak JL; Dagher RK; Corson JM; Wilson RE
    Clin Exp Immunol; 1968 Oct; 3(8):801-8. PubMed ID: 5718504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
    Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
    Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Blood plasma alpha globulin fraction and antilymphocytic serum administered to mice. Effect on host reaction to graft and graft reaction to host (author's transl)].
    Cajthamlová H; Bednarík T
    Cas Lek Cesk; 1978 Apr; 117(15):463-6. PubMed ID: 77732
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
    Monaco AP; Gozzo JJ; Wood ML; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of a heterologous, cutaneous Graft-Versus-Host reaction in mice].
    Brune K
    Z Gesamte Exp Med Einschl Exp Chir; 1969 Sep; 151(1):74-88. PubMed ID: 4391808
    [No Abstract]   [Full Text] [Related]  

  • 11. Modification of the graft-versus-host syndrome by anti-lymphocyte serum treatment of the donor.
    Boak JL; Wilson RE
    Clin Exp Immunol; 1968 Oct; 3(8):795-800. PubMed ID: 5718503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strength of H-2 and non-H-2 antigens as compared in ALS-suppressed recipients.
    Hilgert I; Nouza K
    Folia Biol (Praha); 1970; 16(6):369-73. PubMed ID: 4394676
    [No Abstract]   [Full Text] [Related]  

  • 13. Transient graft-versus-host reaction in the treatment of leukemia in mice.
    Boranić M
    J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
    [No Abstract]   [Full Text] [Related]  

  • 14. Graft-versus-host reactivity and inhibitory serum factors in allograft-tolerant chickens.
    Droege W; Mayor K
    Transplantation; 1975 Jun; 19(6):517-20. PubMed ID: 237355
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of Escherichia coli endotoxin on the graft-versus-host reaction in mice. 3. Runt disease in newborns.
    Skopińska E
    Arch Immunol Ther Exp (Warsz); 1974; 22(3):305-8. PubMed ID: 4151942
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mechanism of a heterologous, cutaneous graft-versus-host reaction in mice. II. Reactivity of graft and host].
    Brune K; Bucher KE
    Z Gesamte Exp Med Einschl Exp Chir; 1971; 156(2):73-86. PubMed ID: 4400329
    [No Abstract]   [Full Text] [Related]  

  • 17. [Various effects of heterologous antithymus- and antilymphocyte serum on the development of the graft-vs-host reaction].
    Biege G; von Broen B
    Exp Pathol (Jena); 1970; 4(4):211-6. PubMed ID: 4399294
    [No Abstract]   [Full Text] [Related]  

  • 18. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of cell dose on mortality from graft-versus-host disease.
    Toya RE; Congdon CC
    Rev Eur Etud Clin Biol; 1971 Feb; 16(2):144-6. PubMed ID: 4396443
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic resistance in the graft-versus-host reaction.
    Sula K; Nouza K
    Exp Clin Immunogenet; 1984; 1(3):175-84. PubMed ID: 6101099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.